http://orcid.org/0000-0001-8317-2286
References
- Yoshimoto Y. Systematic review of the natural history of vestibular schwannoma. J. Neurosurg. 2005;103(1):59–63.
- Kshettry VR, Hsieh JK, Ostrom QT, et al. Incidence of vestibular schwannomas in the United States. J Neurooncol. 2015;124(2):223–228.
- Bakkouri WE, Kania RE, Guichard J-P, et al. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. JNS. 2009;110(4):662–669.
- Herwadker A, Vokurka EA, Evans DGR, et al. Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation. Otol Neurotol. 2005;26(1):86–92.
- Carlson ML, Habermann EB, Wagie AE, et al. The changing landscape of vestibular schwannoma management in the United States – a shift toward conservatism. Otolaryngol Head Neck Surg. 2015;153(3):440–446.
- Hunter JB, Francis DO, O’Connell BP, et al. Single institutional experience with observing 564 vestibular schwannomas: factors associated with tumor growth. Otol Neurotol. 2016;37(10):1630–1636.
- Chen Z, Prasad SC, Di Lella F, et al. The behavior of residual tumors and facial nerve outcomes after incomplete excision of vestibular schwannomas. JNS. 2014;120(6):1278–1287.
- Stangerup S-E, Thomsen J, Tos M, et al. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol. 2010;31(2):271–275.
- Jethanamest D, Rivera AM, Ji H, et al. Conservative management of vestibular schwannoma: predictors of growth and hearing. Laryngoscope. 2015;125(9):2163–2168.
- Agrawal Y, Clark JH, Limb CJ, et al. Predictors of vestibular schwannoma growth and clinical implications. Otol Neurotol. 2010;31(5):807–812.
- Patnaik U, Prasad SC, Tutar H, et al. The long-term outcomes of wait-and-scan and the role of radiotherapy in the management of vestibular schwannomas. Otol Neurotol. 2015;36(4):638–646.
- Sakamoto T, Fukuda S, Inuyama Y. Hearing loss and growth rate of acoustic neuromas in follow-up observation policy. Auris Nasus Larynx. 2001;28 (Suppl):S23–S27.
- Paldor I, Chen AS, Kaye AH. Growth rate of vestibular schwannoma. J Clin Neurosci. 2016;32:1–8.
- Koos WT, Day JD, Matula C, et al. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J. Neurosurg. 1998;88(3):506–512.
- Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Am Acad Otolaryngol Head Neck Surg. 1995;113:179–180.
- Tringali S, Ferber-Viart C, Fuchsmann C, et al. Hearing preservation in retrosigmoid approach of small vestibular schwannomas: prognostic value of the degree of internal auditory canal filling. Otol Neurotol. 2010;31:1469–1472.
- Flint D, Fagan P, Panarese A. Conservative management of sporadic unilateral acoustic neuromas. J Laryngol Otol. 2005;119(6):424–428.
- Malhotra PS, Sharma P, Fishman MA, et al. Clinical, radiographic, and audiometric predictors in conservative management of vestibular schwannoma. Otol Neurotol. 2009;30(4):507–514.
- Kontorinis G, Crowther JA, Iliodromiti S, et al. Neutrophil to lymphocyte ratio as a predictive marker of vestibular schwannoma growth. Otol Neurotol. 2016;37(5):580–585.
- Rogosnitzky M, Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals Int Biometals. 2016;29(3):365–376.